J. Yaouanq

发表

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Simon C. Potter, Joseph T. Glessner, M. Pirinen, 2011, Nature.

Evidence for a two-stage disability progression in multiple sclerosis

Gilles Edan, David Laplaud, Emmanuelle Leray, 2010, Brain : a journal of neurology.

A second-generation genomic screen for multiple sclerosis.

J. Haines, M. Pericak-Vance, S. Schmidt, 2004, American journal of human genetics.

NOD2/CARD15 gene polymorphisms in Crohn's disease: a genotype–phenotype analysis

S. Dréano, J. Mosser, D. Heresbach, 2004, European journal of gastroenterology & hepatology.

Anonymous marker loci within 400 kb of HLA-A generate haplotypes in linkage disequilibrium with the hemochromatosis gene (HFE)

P. Pontarotti, B. Chauvel, A. Kahloun, 1994, American journal of human genetics.

Segregation of genetic hemochromatosis indexed by latent capacity of transferrin.

I. Borecki, D. Rao, J. Lalouel, 1989, American journal of human genetics.

A study of 609 HLA haplotypes marking for the hemochromatosis gene: (1) mapping of the gene near the HLA-A locus and characters required to define a heterozygous population and (2) hypothesis concerning the underlying cause of hemochromatosis-HLA association.

R. Fauchet, G. Edan, M. Simon, 1987, American journal of human genetics.

Genetics of Hemochromatosis: HLA Association and Mode of Inheritance a

R. Fauchet, M. Simon, P. Brissot, 1988 .

Anonymous markers located on chromosome 6 in the HLA-A class I region: allelic distribution in genetic haemochromatosis

P. Pontarotti, A. Kahloun, J. Yaouanq, 1992, Human Genetics.

Familial screening for genetic haemochromatosis by means of DNA markers.

J. L. Le Gall, P. Pontarotti, J. Yaouanq, 1992, Journal of medical genetics.

Percent transferrin saturation in segregating hemochromatosis.

I. Borecki, D. Rao, J. Lalouel, 1990, American journal of medical genetics.

Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia

B. Grosbois, J. Yaouanq, J. Goasguen, 1997, The Lancet.

Non-C282Y familial iron overload: evidence for locus heterogeneity in haemochromatosis.

S. Pinson, J. Yaouanq, H. Plauchu, 1998, Journal of medical genetics.

Renal scintigraphy in insulin-dependent diabetes mellitus: early glomerular and urologic dysfunction.

J. Yaouanq, A. Moisan, J. Le Cloirec, 1990, The Journal of diabetic complications.

HLA class I gene polymorphism in genetic hemochromatosis

R. Fauchet, J. Yaouanq, M. Blayau, 1990, Human Genetics.

Hemochromatosis: diagnosis and quantification of liver iron with gradient-echo MR imaging.

Y Gandon, M Carsin, P. Brissot, 1994, Radiology.

Variant form of STAT4 is associated with primary Sjögren's syndrome

F. Holsboer, M. Clanet, B. Müller-Myhsok, 2008, Genes and Immunity.

Investigation of seven proposed regions of linkage in multiple sclerosis: an American and French collaborative study

J. Haines, M. Pericak-Vance, E. Génin, 2004, Neurogenetics.

HLA-DRB1*15 allele influences the later course of relapsing remitting multiple sclerosis

E. Génin, E. Leray, H. Perdry, 2008, Genes and Immunity.

Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.

M. Clanet, F. Clerget-Darpoux, G. Edan, 1997 .

Familial factors influence disability in MS multiplex families

M. Clanet, G. Edan, D. Brassat, 1999, Neurology.

REEP1 mutations in SPG31: Frequency, mutational spectrum, and potential association with mitochondrial morpho‐functional dysfunction

A. Durr, D. Hannequin, S. Forlani, 2011, Human mutation.

Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA.

G. Lathrop, I. Borecki, D. Rao, 1990, American Journal of Human Genetics.

Significance of interleukin-1beta and interleukin-1 receptor antagonist genetic polymorphism in inflammatory bowel diseases.

G Semana, M Alizadeh, A Dabadie, 1997, The American journal of gastroenterology.

MGAT5 alters the severity of multiple sclerosis

G. Comi, J. Wojcik, G. Edan, 2010, Journal of Neuroimmunology.

Primary liver cancer in genetic hemochromatosis: a clinical, pathological, and pathogenetic study of 54 cases.

P. Brissot, D. Guyader, Y. Deugnier, 1993, Gastroenterology.

HLA alleles, hemochromatosis allele, and serum ferritin in hemodialysis patients.

M. Simon, J. Yaouanq, 1988, Nephron.

The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis.

B. Genetet, P. Guggenbuhl, J. Yaouanq, 1996, Human immunology.

Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE)

B. Chauvel, J. Yaouanq, J. Feingold, 2004, Human Genetics.

Haemochromatosis and HLA–H

P. Fergelot, J. Mosser, I. Gicquel, 1996, Nature Genetics.

Genetic analysis of multiple sclerosis in Europeans: French data

S. Sawcer, A. Compston, E. Génin, 2003, Journal of Neuroimmunology.

A candidate gene for hemochromatosis: frequency of the C282Y and H63D mutations

P. Fergelot, J. Yaouanq, V. David, 1997, Human Genetics.

Genetic interaction of CTLA‐4 with HLA‐DR15 in multiple sclerosis patients

E. Génin, M. Clanet, M. Trojano, 2003, Annals of neurology.

DNA polymorphism related to the idiopathic hemochromatosis gene: evidence in a recombinant family

I. Gicquel, R. Fauchet, M. Simon, 1986, Human Genetics.

Founder Effect in Patients with Unverricht‐Lundborg Disease on Reunion Island

C. Buresi, A. Malafosse, A. Biraben, 2003, Epilepsia.

Serum ferritin as a marker of affection for genetic hemochromatosis.

I. Borecki, D. Rao, J. Lalouel, 1990, Human heredity.

Genetic hemochromatosis: distribution analysis of six laboratory measures of iron metabolism.

I. Borecki, D. Rao, J. Lalouel, 1989, American journal of medical genetics.

Interleukin-1 receptor antagonist gene in multiple sclerosis

M. Clanet, G. Edan, J. Yaouanq, 1997, The Lancet.

Ten‐year prognosis in multiple sclerosis: a better outcome in relapsing−remitting patients but not in primary progressive patients

E. Leray, G. Edan, J. Yaouanq, 2015, European journal of neurology.

‘Clinically definite benign multiple sclerosis’, an unwarranted conceptual hodgepodge: evidence from a 30-year observational study

E. Leray, J. Oger, J. Oger, 2013, Multiple sclerosis.

Ferritin H gene polymorphism in idiopathic hemochromatosis

M. Simon, L. Abel, J. Yaouanq, 2004, Human Genetics.

Long-term survival of patients with multiple sclerosis in West France

E. Leray, S. Morrissey, G. Edan, 2007, Multiple sclerosis.

Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis.

M. Bonnard, P. Guggenbuhl, J. Yaouanq, 1999, Rheumatology.

Small-area distribution of multiple sclerosis incidence in western France: in search of environmental triggers

J. Viel, G. Edan, J. Yaouanq, 2017, International Journal of Health Geographics.

E. Leray, G. Edan, J. Yaouanq, 2015, Acta neurologica Scandinavica.

Evidence for a two-stage disability progression in multiple sclerosis.

E. Leray, J. Oger, G. Edan, 2010, Brain : a journal of neurology.

Evidence for a Two-stage Disability Progression in Multiple Sclerosis

E. Leray, G. Edan, D. Laplaud, 2022 .

Combined segregation and linkage analysis of genetic hemochromatosis using affection status, serum iron, and HLA.

G. Lathrop, I. Borecki, J. Yaouanq, 1990, American journal of human genetics.

Evidence for linkage disequilibrium between HLA-DRB1 gene and multiple sclerosis. The French Research Group on Genetic Susceptibility to MS.

F. Clerget-Darpoux, G. Edan, J. Yaouanq, 1997, Science.

IL 2 RA and IL 7 RA genes confer susceptibility for multiple sclerosis in two independent European populations

F. Holsboer, G. Illei, E. Remmers, 2008 .

[French Society for Human Genetics. "Genetics in Practice" Commission. Core scientific data of use in genetic counseling. Hemochromatosis].

D. Lacombe, J. Yaouanq, J. Feingold, 1999, Annales de genetique.